Journal Home
Search for

Volume 29, Issue 8, Pages 933-942 (August 2005)


View previous. 10 of 18 View next.

Resistance against Friend leukemia virus-induced leukemogenesis in DNA-dependent protein kinase (DNA-PK)-deficient scid mice associated with defective viral integration at the Spi-1 and Fli-1 site

Maki Hasegawaa, Shuichi Yamaguchia, Shiro Aizawab, Hidetoshi Ikedac, Kouichi Tatsumib, Yuko Nodab, Katsuiku Hirokawaa, Masanobu KitagawaaCorresponding Author Informationemail address

Received 5 October 2004; accepted 22 January 2005.

Abstract 

Retroviral DNA integration is mediated by the viral protein integrase. However, elements of the host DNA repair machinery such as the phosphatidylinositol 3-kinase (PI-3K)-related protein kinase family system would play a role in the integration of viral DNA into the host DNA. Here, we show that a host PI-3K-related protein kinase, DNA-dependent protein kinase (DNA-PK), plays a role in the specific integration of retroviral DNA and induction of retroviral diseases in vivo. DNA-PK-deficient scid mice inoculated with Friend leukemia virus (FLV) exhibited a random integration into their genomic DNA and expressed the viral envelope protein gp70. However, the specific integration of FLV at Spi-1 or Fli-1 sites did not occur in association with the significant resistance of scid mice to FLV-induced leukemogenesis. In contrast, the knockout of another member of the PI-3K-related protein kinase family, encoded by the ataxia telangiectasia mutated (ATM) gene, resulted in mice as sensitive to FLV-induced leukemogenesis as the wild type mice. FLV was specifically integrated into the DNA at Spi-1 and Fli-1 sites with significant expression of these transcription factors. These findings indicated that DNA-PK would be essential for controlling the in vivo integration of FLV at specific sites as well as the susceptibility to FLV-induced leukemogenesis.

a Department of Comprehensive Pathology, Aging and Developmental Sciences, Tokyo Medical and Dental University, Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo 13-8519, Japan

b Research Center for Radiation Safety, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan

c Laboratory of Infectious Diseases, National Institute of Animal Health, 3-1-5 Kannondai, Tsukuba City, Ibaraki 305-0856, Japan

Corresponding Author InformationCorresponding author. Tel.: +81 3 5803 5399; fax: +81 3 5803 0123.

PII: S0145-2126(05)00063-9

doi:10.1016/j.leukres.2005.01.016


View previous. 10 of 18 View next.